An Urgent Need in Ulcerative Colitis: Bowel Urgency as a Target for Assessment and Treatment
Sunday, May 07, 2023
7:00 PM –8:00 PM EST
6:00 PM – 7:00 PM CST
5:00 PM – 6:00 PM MST
4:00 PM – 5:00 PM PST
Program Features:
- Interactive, case-based learning environment
- Downloadable Simulation Challenge
- Create your own Personalized Poster
Learning Objectives
Upon the completion of this program, attendees should be able to:
- Assess the safety, efficacy, and mechanisms of action of recently approved and emerging therapies for the treatment of patients with ulcerative colitis
- Explain the impact of bowel urgency on quality of life and clinical outcomes in patients with ulcerative colitis
- Apply optimal strategies to assess and manage bowel urgency in patients with ulcerative colitis
Target Audience
This activity is designed to meet the identified educational needs of gastroenterologists, NPs, PAs, and other clinicians treating patients with ulcerative colitis.
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Physician Credit Designation Statement
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
Joint Accreditation Statement
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure Of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com
Release date: May 07, 2023
Expiration date: May 07, 2024
Estimated time to completion: 1.0 hour
